Literature DB >> 15710767

High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction.

C Tschöpe1, C-T Bock, M Kasner, M Noutsias, D Westermann, P-L Schwimmbeck, M Pauschinger, W-C Poller, U Kühl, R Kandolf, H-P Schultheiss.   

Abstract

BACKGROUND: The etiology of left ventricular (LV) isolated diastolic dysfunction often remains unclear. In the present study, we report a strong association between parvovirus B19 (PVB19) genomes and isolated LV diastolic dysfunction. METHODS AND
RESULTS: In 70 patients (mean+/-SD age, 43+/-11 years) admitted with exertional dyspnea and/or reduced exercise tolerance despite preserved LV systolic contractility (ejection fraction=68%), isolated diastolic dysfunction was clinically suspected. Patients with classic risk factors for diastolic dysfunction such as hypertension, coronary heart disease, diabetes mellitus, or pulmonary disease had been excluded. Diastolic function was assessed by echocardiography and LV and RV catheterization. Endomyocardial biopsies (EMBs) were analyzed for the presence of storage or infiltrative diseases or myocarditis, including molecular screening for cardiotropic virus genomes. In a substudy of 24 patients who reported atypical angina, coronary endothelial function was additionally investigated with a coronary Doppler flow-wire technique. In 37 of 70 patients (53%), isolated diastolic dysfunction was confirmed as the cause of their clinical symptoms. No evidence for cardiac storage or infiltrative diseases was found in these cases, but in 35 of 37 of these patients (95%), cardiotropic virus genomes were detected in EMBs (P<0.001). PVB19 was the most frequent pathogen in 31 of 37 patients (84%). In a subgroup of 10 patients with diastolic dysfunction and coexisting endothelial dysfunction, all 10 (100%) were PVB19 positive.
CONCLUSIONS: PVB19 genomes were predominant in patients with unexplained, isolated diastolic dysfunction. A strong association with the incidence of endothelial dysfunction was obvious, consistent with the hypothesis that PVB19-induced endothelial dysfunction may be a possible pathomechanism underlying diastolic dysfunction.

Entities:  

Mesh:

Year:  2005        PMID: 15710767     DOI: 10.1161/01.CIR.0000155615.68924.B3

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  65 in total

1.  Viral epidemiologic shift in inflammatory heart disease: the increasing involvement of parvovirus B19 in the myocardium of pediatric cardiac transplant patients.

Authors:  John P Breinholt; Mousumi Moulik; William J Dreyer; Susan W Denfield; Jeffrey J Kim; John L Jefferies; Joseph W Rossano; Corey M Gates; Sarah K Clunie; Karla R Bowles; Debra L Kearney; Neil E Bowles; Jeffrey A Towbin
Journal:  J Heart Lung Transplant       Date:  2010-04-24       Impact factor: 10.247

2.  Myocardial parvovirus B19 persistence: lack of association with clinicopathologic phenotype in adults with heart failure.

Authors:  Garrick C Stewart; Javier Lopez-Molina; Raju V S R K Gottumukkala; Gregg F Rosner; Mary S Anello; Jonathan L Hecht; Gayle L Winters; Robert F Padera; Kenneth L Baughman; Myra A Lipes
Journal:  Circ Heart Fail       Date:  2010-11-19       Impact factor: 8.790

3.  Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction.

Authors:  Masaru Obokata; Yogesh N V Reddy; Vojtech Melenovsky; Garvan C Kane; Thomas P Olson; Petr Jarolim; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2018-07-03       Impact factor: 24.094

4.  Frequency and determinants of early rapid filling abnormality.

Authors:  Ian P Clements; David O Hodge; Christopher G Scott
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

5.  Zooming in on the Microvasculature in Heart Failure With Preserved Ejection Fraction.

Authors:  Selma F Mohammed; David T Majure; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2016-07       Impact factor: 8.790

6.  Molecular phenotypes of human parvovirus B19 in patients with myocarditis.

Authors:  C-Thomas Bock; Anja Düchting; Friederike Utta; Eva Brunner; Bui Tien Sy; Karin Klingel; Florian Lang; Meinrad Gawaz; Stephan B Felix; Reinhard Kandolf
Journal:  World J Cardiol       Date:  2014-04-26

7.  Down-regulation of inwardly rectifying Kir2.1 K+ channels by human parvovirus B19 capsid protein VP1.

Authors:  Musaab Ahmed; Bernat Elvira; Ahmad Almilaji; C-Thomas Bock; Reinhard Kandolf; Florian Lang
Journal:  J Membr Biol       Date:  2014-12-09       Impact factor: 1.843

Review 8.  [Molecular mechanisms and consequences of cardiac viral infections].

Authors:  R Kandolf; B Bültmann; K Klingel; C-T Bock
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

Review 9.  Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis?

Authors:  M Pauschinger; M Noutsias; D Lassner; H-P Schultheiss; U Kuehl
Journal:  Clin Res Cardiol       Date:  2006-08-16       Impact factor: 5.460

10.  Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.

Authors:  Kapka Miteva; Sophie Van Linthout; Kathleen Pappritz; Irene Müller; Frank Spillmann; Marion Haag; Harald Stachelscheid; Jochen Ringe; Michael Sittinger; Carsten Tschöpe
Journal:  Stem Cells Transl Med       Date:  2016-07-26       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.